BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 25966971)

  • 1. Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
    Ettle B; Schlachetzki JCM; Winkler J
    Mol Neurobiol; 2016 Jul; 53(5):3046-3062. PubMed ID: 25966971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An emerging role of dysfunctional axon-oligodendrocyte coupling in neurodegenerative diseases.
    Mot AI; Depp C; Nave KA
    Dialogues Clin Neurosci; 2018 Dec; 20(4):283-292. PubMed ID: 30936768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modifications-insight into oligodendrocyte lineage progression, regeneration, and disease.
    Gregath A; Lu QR
    FEBS Lett; 2018 Apr; 592(7):1063-1078. PubMed ID: 29427507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner.
    Ferrer I
    Prog Neurobiol; 2018 Oct; 169():24-54. PubMed ID: 30077775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.
    Armstrong RC; Mierzwa AJ; Sullivan GM; Sanchez MA
    Neuropharmacology; 2016 Nov; 110(Pt B):654-659. PubMed ID: 25963414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau in Oligodendrocytes Takes Neurons in Sickness and in Health.
    LoPresti P
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30111714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.
    Tognatta R; Miller RH
    Neuropharmacology; 2016 Nov; 110(Pt B):539-547. PubMed ID: 27108096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missing in Action: Dysfunctional RNA Metabolism in Oligodendroglial Cells as a Contributor to Neurodegenerative Diseases?
    Hoch-Kraft P; Trotter J; Gonsior C
    Neurochem Res; 2020 Mar; 45(3):566-579. PubMed ID: 30843138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease.
    Merrill JE; Scolding NJ
    Neuropathol Appl Neurobiol; 1999 Dec; 25(6):435-58. PubMed ID: 10632895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease.
    Barateiro A; Brites D; Fernandes A
    Curr Pharm Des; 2016; 22(6):656-79. PubMed ID: 26635271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia regulate central nervous system myelin growth and integrity.
    McNamara NB; Munro DAD; Bestard-Cuche N; Uyeda A; Bogie JFJ; Hoffmann A; Holloway RK; Molina-Gonzalez I; Askew KE; Mitchell S; Mungall W; Dodds M; Dittmayer C; Moss J; Rose J; Szymkowiak S; Amann L; McColl BW; Prinz M; Spires-Jones TL; Stenzel W; Horsburgh K; Hendriks JJA; Pridans C; Muramatsu R; Williams A; Priller J; Miron VE
    Nature; 2023 Jan; 613(7942):120-129. PubMed ID: 36517604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of α-synuclein from neurons to oligodendrocytes triggers myelin sheath destruction in methamphetamine administration mice.
    Ding J; Huang J; Xia B; Hu S; Fan H; Dai J; Li Z; Wang J; Le C; Qiu P; Wang Y
    Toxicol Lett; 2021 Nov; 352():34-45. PubMed ID: 34562559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendroglial Cells in Alzheimer's Disease.
    Butt AM; De La Rocha IC; Rivera A
    Adv Exp Med Biol; 2019; 1175():325-333. PubMed ID: 31583593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of neonatal hypoxia-ischaemia on oligodendrocyte survival, maturation and myelinating potential.
    Ziemka-Nalecz M; Janowska J; Strojek L; Jaworska J; Zalewska T; Frontczak-Baniewicz M; Sypecka J
    J Cell Mol Med; 2018 Jan; 22(1):207-222. PubMed ID: 28782169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendroglia in developmental neurotoxicity.
    Deng W; Poretz RD
    Neurotoxicology; 2003 Mar; 24(2):161-78. PubMed ID: 12606289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Strategies for Leukodystrophic Disorders Resulting from Perinatal Asphyxia: Focus on Myelinating Oligodendrocytes.
    Janowska J; Sypecka J
    Mol Neurobiol; 2018 May; 55(5):4388-4402. PubMed ID: 28660484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO
    Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A silver lining of neuroinflammation: Beneficial effects on myelination.
    Goldstein EZ; Church JS; Hesp ZC; Popovich PG; McTigue DM
    Exp Neurol; 2016 Sep; 283(Pt B):550-9. PubMed ID: 27151600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation.
    Robinson S; Miller RH
    Dev Biol; 1999 Dec; 216(1):359-68. PubMed ID: 10588885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.